Research Article
miR-145-3p Hampers the Malignant Progression of Esophageal Carcinoma via CXCL5 Downregulation
Figure 5
miR-145-3p modulates cell progression in EC through targeting CXCL5. (a, b) CXCL5 mRNA and protein expression in different treatment groups (miR-NC+oe-NC, miR-NC+oe-CXCL5, and miR-mimics+oe-CXCL5). (c) The proliferation of EC9706 cells in each treatment group. (d) The invasive ability of EC9706 cells in each treatment group (100x). (e) The migratory ability of EC9706 cells in each treatment group (40x). (f) The apoptosis rate of EC9706 cells in each treatment group. When the miR-NC+oe-NC group was compared with the miR-NC+oe-CXCL5 group, miR-NC+oe-NC was the control; when the miR-NC+oe-CXCL5 group was compared with the miR-mimics+oe-CXCL5 group, miR-mimics+oe-CXCL5 was the control. .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |